Clinical Trials Browser

Liver Neoplasms × Pluvicto × 90 days × Clear all

NCT06852820 2026-05-08

68Ga-PSMA-11 PET-directed Radioligand Therapy in Metastatic Hepatocellular Carcinoma (HCC)

Phase 2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms